Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis

International Journal of Cancer

Volumn 137, Issue 4, 2015, Pages 878-884

  Rees, Judy R ^a,b   Zens, M Scot ^a   Celaya, Maria O ^a,b   Riddle, Bruce L ^a,b   Karagas, Margaret R ^a,b   Peacock, Janet L ^c,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b New Hampshire State Cancer Registry   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

basal cell carcinoma; squamous cell carcinoma; survival

Indexed keywords

AGE; ARTICLE; BASAL CELL CARCINOMA; CANCER MORTALITY; CANCER SURVIVAL; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SKIN CARCINOMA; SMOKING; SURVIVAL RATE; UNITED STATES; CANCER STAGING; FOLLOW UP; MORTALITY; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84931569365     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29436     Document Type: Article

References (50)

1. Rogers HW, Weinstock MA, Harris AR, et al., Incidence estimate of nonmelanoma skin cancer in the united states, 2006. Arch Dermatol 2010; 146: 283-7.
2. Miller DL, Weinstock MA,. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-8.
3. Birch-Johansen F, Jensen A, Mortensen L, et al., Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 2010; 127: 2190-8.
4. Lindelof B, Sigurgeirsson B, Wallberg P, et al., Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991; 25: 245-8.
5. Teppo L, Dickman PW, Hakulinen T, et al., Cancer patient survival-patterns, comparisons, trends-a population-based cancer registry study in Finland. Acta Oncol 1999; 38: 283-94.
6. Warren S,. Cancer of the skin in relation to multiple malignant growths. JAMA 1940; 115: 1705-7.
7. Frisch M, Hjalgrim H, Olsen JH, et al., Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996; 125: 815-21.
8. Wassberg C, Thorn M, Yuen J, et al., Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 1999; 80: 511 -1 5.
9. Karagas MR, Greenberg ER, Mott LA, et al., Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 157-61.
10. Levi F, La Vecchia C, Te VC, et al., Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998; 147: 722-6.
11. Levi F, Randimbison L, La Vecchia C, et al., Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997; 146: 734-9.
12. Swerdlow AJ, Storm HH, Sasieni PD,. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995; 61: 773-9.
13. Bower CP, Lear JT, Bygrave S, et al., Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England. J Am Acad Dermatol 2000; 42: 988-91.
14. Friedman GD, Tekawa IS,. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000; 11: 891-7.
15. Milan T, Pukkala E, Verkasalo PK, et al., Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000; 87: 283-8.
16. Brewster AM, Alberg AJ, Strickl PT, et al., XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1271-5.
17. Efird JT, Friedman GD, Habel L, et al., Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 2002; 12: 469-75.
18. Troyanova P, Danon S, Ivanova T,. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in bulgaria. Neoplasma 2002; 49: 81-5.
19. Crocetti E, Carli P,. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 2004; 13: 33-7.
20. Maitra SK, Gallo H, Rowland-Payne C, et al., Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer 2005; 92: 570-1.
21. Nugent Z, Demers AA, Wiseman MC, et al., Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2584-90.
22. Rosenberg CA, Greenl P, Khandekar J, et al., Association of nonmelanoma skin cancer with second malignancy. Cancer 2004; 100: 130-8.
23. Roh MR, Shin HJ, Lee SH, et al., Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients. J Dermatol 2012; 39: 541-4.
24. Chen J, Ruczinski I, Jorgensen TJ, et al., Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008; 100: 1215-22.
25. Rees JR, Zens MS, Gui J, et al., Non melanoma skin cancer and subsequent cancer risk. PloS One 2014; 9: e99674
26. Jensen AO, Bautz A, Olesen AB, et al., Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001. Br J Dermatol 2008; 159: 419-25.
27. Jensen AO, Lamberg AL, Jacobsen JB, et al., Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study. Acta Dermato Venereol 2010; 90: 362-7.
28. Jensen AO, Olesen AB, Dethlefsen C, et al., Ten year mortality in a cohort of nonmelanoma skin cancer patients in denmark. J Invest Dermatol 2006; 126: 2539-41.
29. Jensen AO, Olesen AB, Dethlefsen C, et al., Do incident and new subsequent cases of non-melanoma skin cancer registered in a Danish prospective cohort study have different 10-year mortality? Cancer Detect Prev 2007; 31: 352-8.
30. Johannesdottir SA, Lash TL, Jensen AO, et al., Mortality in cancer patients with a history of cutaneous squamous cell carcinoma-a nationwide population-based cohort study. BMC Cancer 2012; 12: 126
31. Kahn HS, Tatham LM, Patel AV, et al., Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998; 280: 910 -1 2.
32. Karjalainen S, Salo H, Teppo L,. Basal cell and squamous cell carcinoma of the skin in Finland. Site distribution and patient survival. Int J Dermatol 1989; 28: 445-50.
33. Talback M, Stenbeck M, Rosen M,. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish cancer registry data. Eur J Cancer 2004; 40: 1361-72.
34. Robinson SN, Zens MS, Perry AE, et al., Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol 2013; 133: 1950-5.
35. Havener LE,. Standards for Cancer Registries, vol. III: Standards for completeness, quality, analysis, and management of data. Springfield (IL): North American Association of Central Cancer Registries, 2004. 180 p (page 48).
36. Bergmann MM, Calle EE, Mervis CA, et al., Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 1998; 147: 556-62.
37. Colditz GA, Martin P, Stampfer MJ, et al., Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986; 123: 894-900.
38. Standards for Cancer Registries. Springfield, Ill.: North American Association of Central Cancer Registries, 2011.
39. WHO. Manual of the international statistical classification of diseases, injuries, and causes of death, based on the recommendations of the Ninth Revision Conference, 1975. Geneva: WHO, 1977.
40. National Center for Health Statistics. National death index user's guide. Hyattsville, MD: National Center for Health Statistics, 2013.
41. Schmults CD, Karia PS, Carter JB, et al., Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013; 149: 541-7.
42. Askling J, Sorensen P, Ekbom A, et al., Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann Intern Med 1999; 131: 655-9.
43. Hjalgrim H, Frisch M, Storm HH, et al., Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Int J Cancer 2000; 85: 639-42.
44. Toro JR, Blake PW, Bjorkholm M, et al., Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia. Haematologica 2009; 94: 1460-4.
45. Brauer JA, Wriston CC, Troxel AB, et al., Characteristics associated with early and late melanoma metastases. Cancer 2010; 116: 415-23.
46. Spratt JS, Jr., Cancer mortality after nonmelanoma skin cancer. JAMA 1999; 281: 325.
47. Soerjomataram I, Louwman WJ, de Vries E, et al., Primary malignancy after primary female breast cancer in the south of the netherlands, 1972-2001. Breast Cancer Res Treat 2005; 93: 91-5.
48. de Vries E, Soerjomataram I, Houterman S, et al., Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol 2007; 165: 966-72.
49. Cambridge B, Cina SJ,. The accuracy of death certificate completion in a suburban community. Am J Forensic Med Pathol 2010; 31: 232-5.
50. Nielsen GP, Bjornsson J, Jonasson JG,. The accuracy of death certificates. Implications for health statistics. Virchows Arch A Pathol Anat Histopathol 1991; 419: 143-6.